查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲 ELISA 诊断测试市场预测至 2030 年 - 区域分析 - 按采用、测试类型、应用程式和最终用户
市场调查报告书
商品编码
1494326

欧洲 ELISA 诊断测试市场预测至 2030 年 - 区域分析 - 按采用、测试类型、应用程式和最终用户

Europe ELISA Diagnostics Tests Market Forecast to 2030 - Regional Analysis - by Adoption, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 110 Pages | 订单完成后即时交付

价格

2022年欧洲ELISA诊断测试市值为3.1959亿美元，预计2030年将达到5.3465亿美元；预计2022年至2030年复合年增长率为6.6%。

人类感染发生率的增加推动了欧洲 ELISA 诊断测试市场

根据世界卫生组织 2020 年报告，全球大部分成年人死亡是由非传染性疾病和慢性病造成的。未来十年，这一数字预计将成长 17%。全世界大约有三分之一的人患有多种慢性疾病。此外，全球每年有 4,100 万人死于非传染性疾病，占总死亡人数的 74%。此外，每年有 1,700 万人在 70 岁前死于非传染性疾病；低收入和中等收入国家占这些过早死亡的 86%。每年有 1,790 万人死于非传染性疾病，其中心血管疾病占死亡率的大部分。癌症、慢性呼吸道疾病和糖尿病紧随其后。在人类中，ELISA 测试被用作检测癌症、传染病、自体免疫、内分泌诊断、免疫学和细胞因子、细胞黏附分子 (CAM) 等的生物标记。 ELISA 检测有助于在诊断过程的早期阶段检测癌症，为患者提供更好的生存机会并在最初获得适当的治疗。因此，全球对 ELISA 检测的需求很高，导致预测期内市场成长。

欧洲 ELISA 诊断测试市场概况

根据胸腔肿瘤学杂誌的报告，肺癌在德国造成显着的发病率、死亡率和社会经济成本。在男性中，肺癌位居第二位，仅次于心血管疾病，2020年占全因死亡率的6.5%。位居第三。因此，随着德国肺癌盛行率的不断上升，在德国医疗系统中实施肺癌筛检和诊断显得至关重要。为了控制德国肺癌的盛行率，市场参与者专注于生产 ELISA 诊断测试。 QIAGEN NV 就是这样的例子之一。 2021 年 5 月，QIAGEN NV 宣布推出首个 FDA 批准的伴随诊断 (CDx) 声称“therascreen KRAS RGQ PCR 试剂盒”，用于识别非小细胞肺癌 (NSCLC) 患者。 therascreen KRAS 试剂盒是第一个获得美国食品和药物管理局 (USFDA) 上市前批准的伴随诊断测试，用于识别 NSCLC 肿瘤组织样本中的 KRAS G12C 突变。因此，癌症盛行率的上升，尤其是德国肺癌的盛行率，以及製造商推出的创新产品推动了德国 ELISA 诊断测试市场的成长。

欧洲 ELISA 诊断测试市场收入及 2030 年预测（百万美元）

欧洲 ELISA 诊断测试市场细分

欧洲 ELISA 诊断测试市场根据采用情况、测试类型、应用程式、最终用户和国家进行细分。根据采用情况，欧洲 ELISA 诊断测试市场分为人类和兽用。 2022 年，人类细分市场将占据更大的市场份额。

就测试类型而言，欧洲ELISA诊断测试市场分为夹心ELISA、间接ELISA、竞争性ELISA以及多重便携式ELISA。 2022 年，间接 ELISA 细分市场占据最大的市场份额。

根据应用，欧洲 ELISA 诊断测试市场分为自体免疫疾病、传染病、癌症诊断、蛋白质定量等。 2022 年，传染病领域占据最大的市场份额。

按最终用户划分，欧洲 ELISA 诊断测试市场分为医院和诊断中心、製药和生物技术公司、兽医医院和诊断实验室等。 2022 年，医院和诊断中心细分市场占据最大的市场份额。

根据国家/地区，欧洲 ELISA 诊断测试市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲 ELISA 诊断测试市场份额中占据主导地位。

Bio-Rad Laboratories Inc.、Idex Laboratories Inc.、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Danaher Corp.、Innovative Diagnostics SAS、DiaSorin SpA、Elabscience Biotechnology Inc. 和 Bio-Tech Dine Corp.是欧洲ELISA 诊断测试市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲 ELISA 诊断测试市场 - 主要产业动态

  • 主要市场驱动因素
    • 动物传染病不断增加
    • 人类感染发生率增加
  • 主要市场限制
    • 产品召回事件
  • 主要市场机会
    • 创新产品发布
  • 未来的趋势
    • 基于 ELISA 的程序的进展

第 5 章：ELISA 诊断测试市场 - 欧洲市场分析

  • 概述
  • ELISA 诊断测试市场收入，2022 - 2030

第 6 章：欧洲 ELISA 诊断测试市场 - 收入和 2030 年预测 - 按采用情况

  • 概述
  • 欧洲 ELISA 诊断测试市场收入份额，按采用情况划分 2022 年和 2030 年 (%)
  • 人类
  • 兽医

第 7 章：欧洲 ELISA 诊断测试市场 - 2030 年收入和预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年 ELISA 诊断测试市场收入份额，按测试类型划分 (%)
  • 夹心ELISA
  • 间接ELISA
  • 竞争性ELISA
  • 多重便携式 ELISA

第 8 章：欧洲 ELISA 诊断测试市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年和 2030 年欧洲 ELISA 诊断测试市场收入份额，按应用划分 (%)
  • 自体免疫疾病
  • 传染病
  • 癌症诊断
  • 蛋白质定量
  • 其他的

第 9 章：欧洲 ELISA 诊断测试市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年欧洲 ELISA 诊断测试市场收入份额（按最终用户划分）（%）
  • 医院和诊断中心
  • 製药与生物技术公司
  • 兽医医院和诊断实验室
  • 其他的

第 10 章：欧洲 ELISA 诊断测试市场 - 收入和 2030 年预测 - 国家分析

  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 11 章：ELISA 诊断测试市场-产业格局

  • 概述
  • ELISA 诊断测试市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Bio-Rad Laboratories Inc
  • Idexx Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • Danaher Corp
  • Innovative Diagnostics SAS
  • DiaSorin SpA
  • Elabscience Biotechnology Inc
  • Bio-Techne Corp

第 13 章：附录

Product Code: BMIRE00029815

The Europe ELISA diagnostics tests market was valued at US$ 319.59 million in 2022 and is expected to reach US$ 534.65 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Increasing Incidence of Human Infections Fuels Europe ELISA Diagnostics Tests Market

According to the WHO Report 2020, noncommunicable and chronic diseases cause the majority of adult deaths worldwide. Over the next ten years, this number is expected to rise by 17%. Roughly one in three persons worldwide deal with several chronic illnesses. Moreover, noncommunicable illnesses account for 41 million annual deaths worldwide, or 74% of all fatalities. Further, 17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities. With 17.9 million fatalities from NCDs each year, cardiovascular illnesses account for the majority of mortality. Cancer, chronic respiratory diseases, and diabetes follow closely behind. In humans, ELISA test is used as a biomarker to detect cancer, infectious diseases, autoimmunity, endocrinology diagnosis, immunology & cytokines, cell adhesion molecules (CAMs), and others. ELISA testing helps detect cancer at the early stage of diagnostic processes, offering a better chance for patient survival and getting appropriate treatment initially. Therefore, demand for ELISA testing is high across the world owing resulting in market growth during the forecast period.

Europe ELISA Diagnostics Tests Market Overview

According to the Journal of Thoracic Oncology report, lung cancer is responsible to cause significant morbidity, mortality, and socioeconomic cost in Germany. In men, lung cancer ranks second after cardiovascular disease, accounting for 6.5% of all-cause mortality in 2020. With an age-standardized incidence rate of 32.7 and 52.1 (per 100,000) in men and women, respectively, lung cancer ranked third in women and second in men in Germany. Therefore, with the rising prevalence of lung cancer in the country, the implementation of lung cancer screening and diagnosis in the German healthcare system is of utmost importance. To control the prevalence of lung cancer in Germany, market players focus on manufacturing ELISA diagnostic tests. QIAGEN N.V. is one such example. In May 2021, QIAGEN N.V. announced the launch of its first FDA-approved companion diagnostic (CDx) claims for the "therascreen KRAS RGQ PCR Kit" to identify non-small cell lung cancer (NSCLC) patients. The therascreen KRAS kit is the first companion diagnostic test to obtain premarket approval from the US Food and Drug Administration (USFDA) to identify the KRAS G12C mutation in samples of NSCLC tumor tissues. Therefore, the rising cancer prevalence, particularly lung cancer in Germany, and innovative product launches by the manufacturers boost the ELISA diagnostic test market growth in Germany.

Europe ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Europe ELISA Diagnostics Tests Market Segmentation

The Europe ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Europe ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Europe ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Europe ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Europe ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Europe ELISA diagnostics tests market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Innovative Diagnostics SAS, DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the Europe ELISA diagnostics tests market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation
    • 1.2.1 Europe ELISA Diagnostic Tests Market - by Adoption
    • 1.2.2 Europe ELISA Diagnostic Tests Market - by Test Type
    • 1.2.3 Europe ELISA Diagnostic Tests Market - by Application
    • 1.2.4 Europe ELISA Diagnostic Tests Market - by End User
    • 1.2.5 Europe ELISA Diagnostic Tests Market - by Country

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe ELISA Diagnostic Test Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Infectious Diseases Among Animals
    • 4.1.2 Increasing Incidence of Human Infections
  • 4.2 Key Market Restraints
    • 4.2.1 Incidents of Product Recalls
  • 4.3 Key Market Opportunities
    • 4.3.1 Innovative Product Launches
  • 4.4 Future Trends
    • 4.4.1 Advancements in ELISA-Based Procedures

5. ELISA Diagnostic Tests Market - Europe Market Analysis

  • 5.1 Overview
  • 5.2 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

6. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

  • 6.1 Overview
  • 6.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • 6.3 Human
    • 6.3.1 Overview
    • 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Veterinary
    • 6.4.1 Overview
    • 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Sandwich ELISA
    • 7.3.1 Overview
    • 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Indirect ELISA
    • 7.4.1 Overview
    • 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Competitive ELISA
    • 7.5.1 Overview
    • 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Multiple & Portable ELISA
    • 7.6.1 Overview
    • 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Autoimmune Diseases
    • 8.3.1 Overview
    • 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Cancer Diagnosis
    • 8.5.1 Overview
    • 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Protein Quantification
    • 8.6.1 Overview
    • 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals & Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical & Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Veterinary Hospitals & Diagnostic Laboratories
    • 9.5.1 Overview
    • 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Europe: ELISA Diagnostic Tests Market
    • 10.1.1 Europe: ELISA Diagnostic Tests Market, by Country
      • 10.1.1.1 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.5 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

11. ELISA Diagnostics Test Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in ELISA diagnostics test Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Bio-Rad Laboratories Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Idexx Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Thermo Fisher Scientific Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Abbott Laboratories
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Danaher Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Innovative Diagnostics SAS
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 DiaSorin SpA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Elabscience Biotechnology Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Financial Overview
    • 12.9.4 SWOT Analysis
    • 12.9.5 Key Developments
  • 12.10 Bio-Techne Corp
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. ELISA Diagnostic Test Market Segmentation
  • Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
  • Table 3. Germany ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. France ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. UK ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. UK ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. UK ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. UK ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Italy ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Italy ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Italy ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Italy ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Spain ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Spain ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Spain ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Spain ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Europe ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Europe ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Europe ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Rest of Europe ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Recent Organic Growth Strategies in ELISA diagnostics Test Market
  • Table 28. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
  • Table 29. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

  • Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
  • Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
  • Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
  • Figure 4. ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
  • Figure 5. Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • Figure 6. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Europe: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. Europe: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 26. Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Growth Strategies in ELISA diagnostics test Market